Roma G, Balbi A, Ermili A
Farmaco Sci. 1977 Jun;32(6):393-403.
Following the procedure we described for synthesizing analogous compounds in Note I (7), reaction of N,N-dialkyl or (N-alkyl,N-phenyl)ethoxycarbonylacetamides with 4-chloro-1,2-phenylendiamine, in the presence of phosphorus oxychloride, afforded 2,3-dihydro-2-oxo-4-dialkyl (N-alkyl,N-phenyl)amino-chloro-1H-1,5-benzodiazepines. When a large amount of phosphorus oxychloride was employed in the reaction, the formation of 2,4-di-(N-alkyl,N-phenyl)amino-3H-1,5-benzodiazepines was achieved, starting from suitable o-phenylendiamines and (N-alkyl,N-phenyl)ethoxycarbonylacetamides. Pharmacological tests were carried out on some compounds described in the present paper and on others reported in the preceding Note (7); in this connection 4-amino-1,5-benzodiazepine derivatives showed weak CNS depressing activity in addition, in some cases, to clear, although moderate, anticonvulsant activity, whereas 2,4-diamino-1,5-benzodiazepine derivatives were practically without effect.
按照我们在注释I(7)中描述的合成类似化合物的方法,在三氯氧磷存在下,N,N-二烷基或(N-烷基,N-苯基)乙氧羰基乙酰胺与4-氯-1,2-苯二胺反应,得到2,3-二氢-2-氧代-4-二烷基(N-烷基,N-苯基)氨基-氯-1H-1,5-苯并二氮杂䓬。当在反应中使用大量三氯氧磷时,从合适的邻苯二胺和(N-烷基,N-苯基)乙氧羰基乙酰胺出发,可得到2,4-二-(N-烷基,N-苯基)氨基-3H-1,5-苯并二氮杂䓬。对本文所述的一些化合物以及前一注释(7)中报道的其他化合物进行了药理试验;就此而言,4-氨基-1,5-苯并二氮杂䓬衍生物除了在某些情况下具有明显但适度的抗惊厥活性外,还表现出较弱的中枢神经系统抑制活性,而2,4-二氨基-1,5-苯并二氮杂䓬衍生物实际上没有作用。